Skip to main content
SpringerLink
Log in

Pyrrolidones as Penetration Enhancers

  • Chapter
Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement

  • 1750 Accesses

Abstract

Pyrrolidines are not widely researched in the recent years as percutaneous penetration enhancers. The toxicity and skin irritancy of these enhancers may be the reason that these enhancers are not studied further. N-methyl-2-pyrrolidone (NMP) and its combination with other solvents such as isopropyl myristate (IPM) are researched in recent years for their synergistic enhancements in the percutaneous absorption of drugs. Pyrrolidones act as penetration enhancers due to their effects on the intercellular lipid bilayers in the stratum corneum. These enhancers penetrate into this region in such amounts that they alter the solubilizing ability of this site, thereby promoting drug partition into the skin. NMP is also known to form hydrogen bonds with basic drugs and cotransport the penetrant across the skin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Akhter SA, Barry BW (1985) Absorption through human skin of ibuprofen and flurbiprofen; effect of dose variation, deposited drug films, occlusion and the penetration enhancer N-methyl-2-pyrrolidone. J Pharm Pharmacol 37(1):27–37

    Article  CAS  PubMed  Google Scholar 

  • Akrill P, Cocker J, Dixon S (2002) Dermal exposure to aqueous solutions of N-methyl pyrrolidone. Toxicol Lett 134:265–269

    Article  CAS  PubMed  Google Scholar 

  • Ansell JM, Fowler JA (1988) The acute oral toxicity and primary ocular and dermal irritation of selected N-alkyl-2-pyrrolidones. Food Chem Toxicol 26:475–479

    Article  CAS  PubMed  Google Scholar 

  • Aungst BJ, Rogers NJ, Shefter E (1986) Enhancement of naloxone penetration through human skin in vitro using fatty acids, fatty alcohols, surfactants, sulfoxides and amides. Int J Pharm 33:225–234

    Article  CAS  Google Scholar 

  • Babu RJ, Pandit JK (2005a) Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems. Int J Pharm 288(2):325–334

    Article  CAS  PubMed  Google Scholar 

  • Babu RJ, Pandit JK (2005b) Effect of penetration enhancers on the transdermal delivery of bupranolol through rat skin. Drug Deliv 12(3):165–169

    Article  CAS  PubMed  Google Scholar 

  • Bachhav YG, Date AA, Patravale VB (2006) Exploring the potential of N-methyl pyrrolidone as a cosurfactant in the microemulsion systems. Int J Pharm 326:186–189

    Article  CAS  PubMed  Google Scholar 

  • Barry BW (1983) Properties that influence percutaneous absorption. In: Dermatological formulations percutaneous absorption. Marcel Dekker, New York, pp 127–233

    Google Scholar 

  • Barry BW (1987) Mode of action of penetration enhancers in human skin. J Control Release 6(1):85–97

    Article  CAS  Google Scholar 

  • Barry BW, Bennett SL (1987) Effect of penetration enhancers on the permeation of mannitol, hydrocortisone and progesterone through human skin. J Pharm Pharmacol 39:535–546

    Article  CAS  PubMed  Google Scholar 

  • Barry BW, Williams AC (1995) Permeation enhancement through skin. In: Swarbrick J, Boylon JC (eds) Encyclopedia of pharmaceutical technology, vol 12. Marcel Dekker Inc, New York, pp 449–493

    Google Scholar 

  • Barry BW, Southwell D, Woodford R (1984) Optimization of bioavailability of topical steroids: penetration enhancers under occlusion. J Invest Dermatol 82:49–52

    Article  CAS  PubMed  Google Scholar 

  • Becci PJ, Knickerbocker MJ, Reagan EL, Parent RA, Llewellyn WB (1982) Teratogenicity study of N-methylpyrrolidone after dermal application to Sprague-Dawley rats. Fundam Appl Toxicol 2:73–76

    Article  CAS  PubMed  Google Scholar 

  • Bennett SL, Barry BW, Woodford R (1984) Optimization of bioavailability of topical steroids: non-occluded penetration enhancers under thermodynamic control. J Pharm Pharmacol 37:298–304

    Article  Google Scholar 

  • Bhatia KS, Singh J (1997) Percutaneous absorption of LHRH through porcine skin: effect of N-Methyl-2-pyrrolidone and isopropyl myristate. Drug Dev Ind Pharm 23:1111–1114

    Article  CAS  Google Scholar 

  • Bonina F, Santagati NA, Puglia C (2003) Ketoprofen 1-alkylazacycloalkan-2-one esters as dermal prodrugs: in vivo and in vitro evaluations. Drug Dev Ind Pharm 29(2):181–190

    Article  CAS  PubMed  Google Scholar 

  • Chow ST, Ng TL (1983) The biodegradation of N-methyl-2-pyrrolidone in water by sewage bacteria. Water Res 17(1):117–118

    Article  CAS  Google Scholar 

  • Cross SE, Pugh WJ, Hadgraft J, Roberts MS (2001) Probing the effect of vehicles on topical delivery: understanding the basic relationship between solvent and solute penetration using silicone membranes. Pharm Res 18:999–1005

    Article  CAS  PubMed  Google Scholar 

  • E.I. du Pont de Nemours and Company, Wilmington, DE (1976) Primary skin irritation and sensitization test on guinea pigs. Haskell Laboratory Report No. 307–776

    Google Scholar 

  • El-Hinnawi MA, Najib NM (1987) Ibuprofen-polyvinylpyrrolidone dispersions. Proton nuclear magnetic resonance and infrared studies. Int J Pharm 37:175–177

    Article  CAS  Google Scholar 

  • Godavarthy SS, Yerramsetty KM, Rachakonda VK, Neely BJ, Madihally SV, Robinson RL Jr, Gasem KA (2009) Design of improved permeation enhancers for transdermal drug delivery. J Pharm Sci 98:4085–4099

    Article  CAS  PubMed  Google Scholar 

  • Godwin DA, Michniak BB, Player MR, Sowell JW (1997) Transdermal and dermal enhancing activity of pyrrolidinones in hairless mouse skin. Int J Pharm 155:241–250

    Article  CAS  Google Scholar 

  • Hoelgaard A, Mollgaard B, Baker E (1988) Effect of N-methyl pyrrolidone and polar lipids on percutaneous drug transport. Int J Pharm 43:233–240

    Google Scholar 

  • Jouyban A, Fakhree MAA, Shayanfar A (2010) Review of pharmaceutical applications of N-ethyl-2-pyrrolidone. J Pharm Sci 13(4):524–535

    CAS  Google Scholar 

  • Kakubari I, Nakamura N, Takayasu T, Yamauchi H, Takayama S, Takayama K (2006) Effects of solvents on skin permeation of formoterol fumarate. Biol Pharm Bull 29(1):146–149

    Article  CAS  PubMed  Google Scholar 

  • Karande P, Mitragotri S (2009) Enhancement of transdermal drug delivery via synergistic action of chemicals. Biochim Biophys Acta 1788(11):2362–2373

    Article  CAS  PubMed  Google Scholar 

  • Kikwai L, Babu RJ, Prado R, Kolot A, Armstrong CA, Ansel JC et al (2005) In vitro and in vivo evaluation of topical formulations of Spantide II. AAPS PharmSciTech 6(4):E565–E572

    Article  PubMed Central  PubMed  Google Scholar 

  • Kim YH, Ghanem AH, Mahmoud H, Higuchi WI (1992) Short chain alkanols as transport enhancers for lipophilic and polar/ionic permeants in hairless mouse skin: mechanism (s) of action. Int J Pharm 80(1):17–31

    Article  CAS  Google Scholar 

  • Koizumi A, Fujii M, Kondoh M, Watanabe Y (2004) Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol. Eur J Pharm Biopharm 57:473–478

    Article  CAS  PubMed  Google Scholar 

  • Lambert WJ, Kudla RJ, Holland JM, Curry JT (1993) A biodegradable transdermal penetration enhancer based on N-(2-hydroxyethyl)-2-pyrrolidone. I. Synthesis and characterization. Int J Pharm 95:181–192

    Article  CAS  Google Scholar 

  • Lee PJ, Langer R, Shastri VP (2003) Novel microemulsion enhancer formulation for simultaneous transdermal delivery of hydrophilic and hydrophobic drugs. Pharm Res 20:264–269

    Article  CAS  PubMed  Google Scholar 

  • Lee PJ, Langer R, Shastri VP (2005) Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport. J Pharm Sci 94:912–917

    Article  CAS  PubMed  Google Scholar 

  • Lee PJ, Ahmad N, Langer R, Mitragotri S, Prasad Shastri V (2006) Evaluation of chemical enhancers in the transdermal delivery of lidocaine. Int J Pharm 308:33–39

    Article  CAS  PubMed  Google Scholar 

  • Ma X, Fang L, Guo JP, Zhao N, He ZG (2010) Effect of counter-ions and penetration enhancers on the skin permeation of flurbiprofen. J Pharm Sci 99:1826–1837

    CAS  PubMed  Google Scholar 

  • Mollgaard B, Hoelgaard A, Baker E (1988) Vehicle effects on topical drug delivery: effect of N-methyl pyrrolidone, polar lipids and Azone on percutaneous drug transport. Proc Int Symp Controlled Rel Bioact Mater 15:209

    Google Scholar 

  • Nair A, Reddy C, Jacob S (2009) Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis. Skin Res Technol 15:187–194

    Article  PubMed  Google Scholar 

  • Naito SI, Nakamori S, Awataguchi M, Nakayama T, Tominaga H (1985) Observations on and pharmacokinetic discussion of percutaneous absorption of mefenamic acid. Int J Pharm 24:127–147

    Article  CAS  Google Scholar 

  • Ogiso T, Hata T, Iwaki M, Tanino T (2001) Transdermal absorption of bupranolol in rabbit skin in vitro and in vivo. Biol Pharm Bull 24:588–591

    Article  CAS  PubMed  Google Scholar 

  • Payan JP, Boudry I, Beydon D, Fabry JP, Grandclaude MC, Ferrari E et al (2003) Toxicokinetics and metabolism of N-[(14)C]N-methyl-2-pyrrolidone in male Sprague-Dawley rats: in vivo and in vitro percutaneous absorption. Drug Metab Dispos 31:659–669

    Article  CAS  PubMed  Google Scholar 

  • Rachakonda VK, Yerramsetty KM, Madihally SV, Robinson RL, Gasem KA (2008) Screening of chemical penetration enhancers for transdermal drug delivery using electrical resistance of skin. Pharm Res 25:2697–2704

    Article  CAS  PubMed  Google Scholar 

  • Santos GC, Baker RW (1993) Transdermal enhancer patent literature. J Control ReIease 25:1–20

    Article  Google Scholar 

  • Sasaki H, Kojima M, Mori Y, Nakamura J, Shibasakl J (1988) Enhancing effects of pyrrolidone derivatives on transdermal drug delivery. I. Int J Pharm 44:15–24

    Article  CAS  Google Scholar 

  • Sasaki H, Kojima M, Nakamura J, Shlhasaki J (1990a) Enhancing effect of pyrrolidone derivatives on the transdermal penetration of sulfaguanidine, aminopyrine and sudan Ill. J Pharmacobiodyn 13:200–205

    Article  CAS  PubMed  Google Scholar 

  • Sasaki H, Kojima M, Morl Y, Nakamura J, Shlbasakl J (1990b) Enhancing effect pyrrolidone derivatives on transdermal drug delivery. II. Effect of application concentration and pretreatment of enhancer. Int J Pharm 60:177–183

    Article  CAS  Google Scholar 

  • Sasaki H, Kojima M, Nakamura J, Shlbasaki J (1990c) Enhancing effect of pyrrolidone derivatives on transdermal penetration of phenolsulfonphthalein and indomethacin from aqueous vehicle. Chem Pharm Bull 38:797–799

    Article  CAS  PubMed  Google Scholar 

  • Sasaki H, Kojima M, Nakamura J, Shibasaki J (1990d) Enhancing effect of combining two pyrrolidone vehicles on transdermal drug delivery. J Pharm Pharmacol 42:196–199

    Article  CAS  PubMed  Google Scholar 

  • Sasaki H, Kishikawa M, Nakamura J, Shibasaki J (1990e) Effect of pyrrolidone derivatives on lipid membrane and protein conformation as transdermal penetration enhancer. J Pharmacobiodyn 13:468–474

    Article  CAS  PubMed  Google Scholar 

  • Sasaki H, Kojima M, Morl Y, Nakamura J, ShlbaSaki J (1991) Enhancing effect 0 pyrrolidone derivatives on transdermal penetration of 5-fluorouracil, triamcinolone acetonide indomethacin, and flurbiprofen. J Pharm Sci 80:533–538

    Article  CAS  PubMed  Google Scholar 

  • Sasaki H, Nishida K, Nakamura J (1995) Pyrrolidones as penetration enhancers. In: Maibach HI, Smith EW (eds) Percutaneous penetration enhancers. CRC Press, Boca Raton, pp 211–220

    Google Scholar 

  • Shah HS, Tojo K, Chien YW (1992) Enhancement of in vitro skin permeation of verapamil. Drug Dev Ind Pharm 18:1461–1476

    Article  CAS  Google Scholar 

  • Shishu, Aggarwal N (2006) Preparation of hydrogels of griseofulvin for dermal application. Int J Pharm 326:20–24

    Article  CAS  PubMed  Google Scholar 

  • Southwell D, Barry BW (1983) Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds, water, n-alkanols and caffeine. J Invest Dermatol 80:507–514

    Article  CAS  PubMed  Google Scholar 

  • Southwell D, Barry BW (1984) Penetration enhancement in human skin: effect of 2-pyrrolidone, dimethylformamide and increased hydration on finite dose permeation of aspirin and caffeine. Int J Pharm 22:291–298

    Article  CAS  Google Scholar 

  • Strickley RG (2004) Solubilizing excipients in oral and injectable formulations. Pharm Res 21(2):201–230

    Article  CAS  PubMed  Google Scholar 

  • Suwanpidokkul N, Thongnopnua P, Umprayn K (2004) Transdermal Delivery of Zidovudine (AZT): the effects of vehicles, enhancers, and polymer membranes on permeation across cadaver pig skin. AAPS PharmSciTech 5(3):1–8

    Article  Google Scholar 

  • Uch AS, Hesse U, Dressman JB (1999) Use of 1-methyl-pyrrolidone as a solubilizing agent for determining the uptake of poorly soluble drugs. Pharm Res 16:968–971

    Article  CAS  PubMed  Google Scholar 

  • Walters KA (1987) Penetration enhancers and their use in transdermal therapeutic systems. In: Hadgraft J, Guy RH (eds) Transdermal drug delivery, developmental issues and research initiatives. Marcel Dekker Inc, New York, pp 197–246

    Google Scholar 

  • Walters KA, Roberts MS (2002) The structure and function of skin. In: Walters KA (ed) Dermatological and topical formulations. Marcel and Dekker Inc, New York, pp 1–42

    Chapter  Google Scholar 

  • Warner KS, Li SK, Higuchi WI (2001) Influences of alkyl group chain length and polar head group on chemical skin permeation enhancement. J Pharm Sci 90:1143–1153

    Article  CAS  PubMed  Google Scholar 

  • Williams AC, Barry BW (2012) Penetration enhancers. Adv Drug Deliv Rev 64:128–137

    Article  Google Scholar 

  • Yoneto K, Ghanem AH, Higuchi WI, Peck KD, Li SK (1995) Mechanistic studies of the 1-alkyl-2-pyrrolidones as skin permeation enhancers. J Pharm Sci 84:312–317

    Article  CAS  PubMed  Google Scholar 

  • Zheng WW, Zhao L, Wei YM, Ye Y, Xiao SH (2010) Preparation and the in vitro evaluation of nanoemulsion system for the transdermal delivery of granisetron hydrochloride. Chem Pharm Bull 58(8):1015–1019

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, 36849, USA

    R. Jayachandra Babu PhD

  2. Department of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University, Auburn, AL, USA

    Li Chen

Authors
  1. R. Jayachandra Babu PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Li Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Jayachandra Babu PhD .

Editor information

Editors and Affiliations

  1. Department of Manufacturing, Apoteka "Beograd", Belgrade, Serbia

    Nina Dragicevic

  2. Dermatology Clinic, University of California San Francisco Dermatology Clinic, San Francisco, USA

    Howard I. Maibach

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Babu, R.J., Chen, L. (2015). Pyrrolidones as Penetration Enhancers. In: Dragicevic, N., Maibach, H. (eds) Percutaneous Penetration Enhancers Chemical Methods in Penetration Enhancement. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-47039-8_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-47039-8_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-47038-1

  • Online ISBN: 978-3-662-47039-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation